NTI 4.11% 7.0¢ neurotech international limited

Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint, page-39

  1. 6,421 Posts.
    lightbulb Created with Sketch. 688
    What the hell does that screen shot even provide that suggests a rebound? Name one?

    I look straight at some key words 'FDA Approved'
    Its a whole different ball game.

    NTI cannot pay for the trials. Duthy said it.
    I might get out even if I'm lucky. I'll just take a small risk and wait for the TGA meeting results. Certainly not holding my breath.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.